Filed: 5/12/2023ACC: 0001420506-23-001021
📋 What this filing means
PROSIGHT MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $210.94M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$210.94M
Total AUM (reported)
22.33M
Total Shares
Allocation by class
COM$142.36M67.5%
SHS$45.78M21.7%
SPON ADR$14.51M6.9%
COM NEW$4.92M2.3%
CALL$2.17M1.0%
COM PAR $.01$449.4K0.2%
COMMON STOCK$433.9K0.2%
Portfolio Concentration
Top 3$49.82M23.6%
4–10$67.39M31.9%
11–25$77.27M36.6%
Rest$16.45M7.8%
Top 3 weight
23.6%
Top 10 weight
55.6%
Voting Authority Distribution
Total shares with voting rights: 22.33M
Sole
Full voting authority
22.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
PROTHENA CORP PLC
SOLEShares447.09K
TypeSH
Market value$21.67M
10.27%
Sole
447.09K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares375.50K
TypeSH
Market value$14.51M
6.88%
Sole
375.50K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares567.83K
TypeSH
Market value$13.64M
6.47%
Sole
567.83K
Shared
0.00
None
0.00
HUMANA INC
SOLEShares24K
TypeSH
Market value$11.65M
5.52%
Sole
24K
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares161.40K
TypeSH
Market value$10.20M
4.84%
Sole
161.40K
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares3.20M
TypeSH
Market value$10.02M
4.75%
Sole
3.20M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.07M
TypeSH
Market value$8.96M
4.25%
Sole
1.07M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares316.17K
TypeSH
Market value$8.91M
4.23%
Sole
316.17K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PUB L
SOLEShares81.03K
TypeSH
Market value$8.84M
4.19%
Sole
81.03K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.54M
TypeSH
Market value$8.81M
4.17%
Sole
1.54M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares80K
TypeSH
Market value$8.10M
3.84%
Sole
80K
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares1.49M
TypeSH
Market value$7.70M
3.65%
Sole
1.49M
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares3.26M
TypeSH
Market value$6.35M
3.01%
Sole
3.26M
Shared
0.00
None
0.00
ARCTURUS THERAPEUTICS HLDGS
SOLEShares255K
TypeSH
Market value$6.11M
2.90%
Sole
255K
Shared
0.00
None
0.00
SHATTUCK LABS INC
SOLEShares2.02M
TypeSH
Market value$5.94M
2.82%
Sole
2.02M
Shared
0.00
None
0.00
ABCELLERA BIOLOGICS INC
SOLEShares753.53K
TypeSH
Market value$5.68M
2.69%
Sole
753.53K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares10.94K
TypeSH
Market value$5.17M
2.45%
Sole
10.94K
Shared
0.00
None
0.00
OPTION CARE HEALTH INC
SOLEShares154.90K
TypeSH
Market value$4.92M
2.33%
Sole
154.90K
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares48.35K
TypeSH
Market value$4.31M
2.04%
Sole
48.35K
Shared
0.00
None
0.00
CUE BIOPHARMA INC
SOLEShares1.15M
TypeSH
Market value$4.11M
1.95%
Sole
1.15M
Shared
0.00
None
0.00
JOHNSON & JOHNSON
SOLEShares25.21K
TypeSH
Market value$3.91M
1.85%
Sole
25.21K
Shared
0.00
None
0.00
INARI MED INC
SOLEShares62.08K
TypeSH
Market value$3.83M
1.82%
Sole
62.08K
Shared
0.00
None
0.00
ALDEYRA THERAPEUTICS INC
SOLEShares383.45K
TypeSH
Market value$3.81M
1.81%
Sole
383.45K
Shared
0.00
None
0.00
PACIRA BIOSCIENCES INC
SOLEShares91.12K
TypeSH
Market value$3.72M
1.76%
Sole
91.12K
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares900.60K
TypeSH
Market value$3.61M
1.71%
Sole
900.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PROTHENA CORP PLCSOLE | SHS | 447.09K | SH | $21.67M 10.27% | 447.09K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 375.50K | SH | $14.51M 6.88% | 375.50K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 567.83K | SH | $13.64M 6.47% | 567.83K | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 24K | SH | $11.65M 5.52% | 24K | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 161.40K | SH | $10.20M 4.84% | 161.40K | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM | 3.20M | SH | $10.02M 4.75% | 3.20M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.07M | SH | $8.96M 4.25% | 1.07M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 316.17K | SH | $8.91M 4.23% | 316.17K | 0.00 | 0.00 |
HORIZON THERAPEUTICS PUB LSOLE | SHS | 81.03K | SH | $8.84M 4.19% | 81.03K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.54M | SH | $8.81M 4.17% | 1.54M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 80K | SH | $8.10M 3.84% | 80K | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 1.49M | SH | $7.70M 3.65% | 1.49M | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | SHS | 3.26M | SH | $6.35M 3.01% | 3.26M | 0.00 | 0.00 |
ARCTURUS THERAPEUTICS HLDGSSOLE | COM | 255K | SH | $6.11M 2.90% | 255K | 0.00 | 0.00 |
SHATTUCK LABS INCSOLE | COM | 2.02M | SH | $5.94M 2.82% | 2.02M | 0.00 | 0.00 |
ABCELLERA BIOLOGICS INCSOLE | COM | 753.53K | SH | $5.68M 2.69% | 753.53K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 10.94K | SH | $5.17M 2.45% | 10.94K | 0.00 | 0.00 |
OPTION CARE HEALTH INCSOLE | COM NEW | 154.90K | SH | $4.92M 2.33% | 154.90K | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 48.35K | SH | $4.31M 2.04% | 48.35K | 0.00 | 0.00 |
CUE BIOPHARMA INCSOLE | COM | 1.15M | SH | $4.11M 1.95% | 1.15M | 0.00 | 0.00 |
JOHNSON & JOHNSONSOLE | COM | 25.21K | SH | $3.91M 1.85% | 25.21K | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 62.08K | SH | $3.83M 1.82% | 62.08K | 0.00 | 0.00 |
ALDEYRA THERAPEUTICS INCSOLE | COM | 383.45K | SH | $3.81M 1.81% | 383.45K | 0.00 | 0.00 |
PACIRA BIOSCIENCES INCSOLE | COM | 91.12K | SH | $3.72M 1.76% | 91.12K | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 900.60K | SH | $3.61M 1.71% | 900.60K | 0.00 | 0.00 |
Page 1 of 2